News & Events about Nyxoah Sa.
INSIDE INFORMATIONREGULATED INFORMATION Nyxoah Announces Achievement of Key Clinical and Regulatory MilestonesAll 115 patients implanted in DREAM U.S. pivotal studyFirst DREAM PMA module submittedFirst patient implanted in ACCCESS U.S. pivotal study Mont-Saint-Guibert, Belgium March 6, 2023, 7:30am ...
Nyxoah and Acurable Enter into Distribution Agreement in Germany for the AcuPebble SA100 Home Sleep Test Mont-Saint-Guibert, Belgium August 2, 2022, 8:00am CET / 2:00am ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(Nyxoah or the Company), a medical technology company focused on the development and ...
REGULATED INFORMATIONINSIDE INFORMATION Nyxoah Receives FDA IDE Approval to Initiate the ACCCESS Study of Genio in Complete Concentric Collapse Patients First ACCCESS patient expected to be implanted in Q4 2022 Mont-Saint-Guibert, Belgium July 11, 2022, 8:00am CET / 2:00am ET Nyxoah SA (Euronext ...
REGULATED INFORMATION Nyxoah Reports First Quarter 2022 Financial and Operating Results Mont-Saint-Guibert, Belgium May 10, 2022, 08:50pm CET / 2:50pm ET Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(Nyxoah or the Company), a medical technology company focused on the development and commercialization ...
REGULATED INFORMATIONMay 6, 2022, 7:00am CET / 1:00am ET NYXOAH SA(Euronext Brussels: NYXH)Rue Edouard Belin 12, 1435 Mont-Saint-Guibert, Belgium(hereinafter the Company) Invitation to attend the annual and the extraordinary shareholders meetings of the Company to be held onJune 8, 2022 The board of...